H etiologic agent of acquired immunodeficiency syndrome (AIDS), is a lentivirus that completes its replicative cycle by budding through the host cell membrane, acquiring host-derived and virus-encoded components in the process. Subsequent rounds of replication require an intact lipid envelope containing the virally encoded envelope proteins necessary for receptor binding.' It has been suggested that perturbation of the HIV-1 envelope may be a suitable approach to inactivating HIV-l.* Compounds that fluidize membranes by removing cholesterol (AL721)3 or by complexing membrane cholesterol (amphotericin B methyl ester)4 can inhibit HIV-1 replication in vitro. Although their precise mode of action has yet to be defined, these compounds may reduce HIV-1 infectivity by perturbing the envelope of HIV-1. We therefore investigated the activity of another membrane active agent, ozone, on HIV-1 infectivity in vitro.
Ozone, the triatomic allotrope of oxygen, is an extremely potent oxidant that has been shown to possess broad spectrum antimicrobial a~tivity.'.~ It has been widely used in sewage treatment, in water purification, and in medicine.'.'" In particular, ozone has been shown to be effective against a number of enveloped and nonenveloped viral species, with enveloped viruses being more susceptible to ozone inactivation than those lacking lipid envelopes?"'"* We report on the in vitro inactivation of HIV-1 in cell culture media and deliberately infected factor VI11 preparations at concentrations of ozone that are not toxic to target cells, while maintaining the biologic activity of factor VIII. We also for the same time period. The data indicate that the antiviral effects of ozone include viral particle disruption, reverse transcriptase inactivation, and/or a perturbation of the ability of the virus to bind to its receptor on target cells. Ozone treatment offers promise as a means to inactivate human retroviruses in human body fluids and blood product preparations. 0 1991 by The American Society of Hemetology.
investigated the mechanism by which ozone mediates its antiviral effect.
MATERIALS AND METHODS
The CD4a' T-cell line HUT 78'' was maintained in RPMI 1640 + 10% heat-inactivated fetal bovine serum (FBS) + 1% penicillinlstreptomycin (complete RPMI; all from GIBCO, Grand Island, NY) at 37"C, 5% CO, humidified atmosphere. HUT 78 cells served as the target cells in the HIV-1 inactivation studies. HUT 78/HIV-1,, is a cell line stably infected with an isolate of HIV-1 from our laboratory (AAV).I4 HUT 78/HIV-l,, served as the source of HIV-1 for the inactivation studies. Cell-free conditioned media from HUT 78/HIV-l,, (HIV-l,, CM) was harvested by centrifugation (1,200g ) and filtered through a 0.45-pm filter (Nalgene, Rochester, NY). This virus preparation was titrated for production of progeny HIV-1 p24 in HUT 78 according to the infectivity assay described below. Factor VI11 preparations used were either nonconcentrated, frozen, HIV-1-negative human plasma or immunoaffinity-purified human factor VI11 (Monoclate; Armour Pharmaceuticals, Kankakee, IL). Factor VI11 activity was determined in a one-stage assay.ls Ozone was generated from medical grade oxygen by electrical corona arc discharge in a commercial ozone generator (Hansler GmbH, Iffezheim-Baden, Germany). Ozone was delivered into cell culture medium or factor VI11 preparations through a closed hollow fiber system ( Fig 1A) as a stream of ozoneloxygen in carrier nitrogen.I6 The hollow fiber cartridge, virus reservoir, peristaltic pump, and all connecting lines were confined to a laminar flow biohazard hood. Figure 1B shows a closeup diagram of the hollow fiber gas exchange cartridge. The micropores of the hollow fiber are of sufficient size to allow for ozone to diffuse from the extracapillary space into the liquid phase, but small enough to prevent liquid from leaking back into the extracapillary space. Ozone and the liquid phase were pumped in a countercurrent fashion with respect to one another to maximize ozone diffusion. Ozone levels in the system were measured using a Dasibi model 1008 ozone monitor (Dasibi, Glendale, CA).
For this and all studies described, 300 mL of Hanks' balanced salt solution (HBSS) were passed for 1 hour at a flow rate of 100 mL/min through the hollow fiber cartridge, reservoir, and connecting lines to moisten the fibers and other components. The system was then drained and 450 mL of cell-free HIV-lAAv CM containing one-half of an infectious unit of HIV-1 was added to the reservoir. For our purposes, one-half of an infectious unit is defined as the dilution of virus that yields 50% of the maximum amount of progeny HIV-1 p24 antigen 5 days postinfection in the virus infectivity assay described below. The titration curve for virus used in these assays is shown in Fig 2. As can be seen, the detection of expressed HIV-1 p24 is linear up to a concentration of 1:4 dilution of input virus, with a maximum detection of 3,000 pg of HIV-1 p24. Hence, a dilution of approximately 1:24 of stock virus was used as one-half of an infectious unit.
Cells and virus.
Factor WII.
Ozone generation and delivey. A full infectious unit would be a dilution of 1:12. The CM (final protein concentration, 35 mg/mL) was then pumped through the system at a rate of 100 mL/min. Ozone flowed through the extracapillary space of the hollow fiber cartridge at the concentrations and times indicated. To find a threshold virucidal dose of ozone, ozone concentrations were sequentially elevated on an hourly basis (ie, 1 hour at 200 ppm, 1 hour at 400 ppm, etc) (Figs 3A and 4A). The time parameter (abscissa) is a composite of the total time of exposure. For N, only experiments, carrier N, alone flowed through the cartridge. For pump only experiments, no gas was introduced into the cartridge, although the cartridge ports were opened to filtered room air. At the times indicated, 1 mL samples of treated CM were removed for use in the virus infectivity assay described below.
HIV-I inactivation studies.
One million HUT 78 cells were pelleted in 15-cm3 sterile tubes and resuspended in 50 pL of HIV-1-containing CM. Cells were exposed to the CM for 1 hour at 37'C and 5% CO, in wells of a 24-well plate. Five days postinfection the CM were sampled and assayed for viral p24 using a commercial antigen capture assay (Cellular Products, Buffalo, NY).'
In those experiments investigating the degree to which ozone inactivates HIV-1, the HIV-1 infectivity assay was modified." Serial 10-fold dilutions of nonozonated HIV-1 were introduced into the assay system while ozone-treated HIV-1-spiked CM or human plasma was used undiluted. The cultures were assayed for HIV-1 p24 twice a week up until day 28. Results are expressed as a mean of a minimum of six separate experiments, each consisting of triplicate runs. Results are expressed as picograms per milliliter HIV-1 infectivity assay. rations were thawed at 4°C in an ice water bath and pooled. Pooled material was separated into two 250 mL aliquots. The first aliquot was diluted with 250 mL Dulbecco's phosphate-buffered saline (PBS) (pH 7.5) and added to the hollow fiber system (final protein concentration, 400 mg/mL). It should be noted that for this particular experiment the hollow fiber system was prewashed with Dulbecco's PBS for 1 hour before addition of diluted factor VIII. A sample of diluted factor VI11 was removed and the remaining diluted factor VI11 was pumped through the hollow fiber system. One hour, no gas (pump only) and one hour, nitrogen only (N, only) samples were removed. Ozone was then flowed through the system at the sequentially escalating concentrations indicated and samples were removed at hourly intervals. All samples were frozen for later assay of factor VI11 activity.
The second 250 mL aliquot of factor VI11 was combined with 250 mL of cell-free HUT 78/HIV-l,, containing a full infectious unit of HIV-1. This preparation (final concentration, 435 mg protein/ mL) was then added to the hollow fiber system prewashed with HBSS. The HIV-l-containing factor VI11 preparation was pumped through the hollow fiber system and sequentially treated with room air only, N2 only, and escalating ozone concentrations, as above. Samples were removed at the times indicated and 50 WL of this material was used to infect 1 x lo6 HUT 78 cells, as described above. CM were sampled 5 days postinfection and assayed for Next, a similarly prepared aliquot of human plasma diluted in PBS and spiked with HIV-1 (final protein concentration, 435 mg/mL) was treated in the hollow fiber system continuously at 1,200 ppm ozone over 6 hours. At various time intervals, samples were removed and analyzed for either HIV-1 infectivity or factor VI11 activity.
Finally, 14 vials of affinity-purified factor VIII were reconstituted with 5 mL of H,O each and diluted with 80 mL of PBS containing 1% human serum albumin. This mixture was added to 150 mL of HIV-l,, CM. After circulating this material several times through the moistened cartridge, the final protein concentration was 35 mg/mL (primarily from the HIV-1," CM) and the final factor VI11 concentration was 10 IU/mL. This material was then subjected to treatment with 1,200 ppm ozone for 6 hours and analyzed periodically for HIV-1 infectivity and factor VI11 activity.
To ascertain whether ozone inactivated HIV-1 by directly perturbing the lipid envelope HIV-1 p24. For personal use only. on November 15, 2017. by guest www.bloodjournal.org From of the virus, ozone-treated and nontreated HIV-1 preparations were analyzed for the presence of intact virions on sucrose density gradients." Briefly, untreated HIV-1 preparations or preparations treated continuously with 1,200 ppm ozone for 2 hours were concentrated by centrifugation at 40,00$ for 2 hours and applied to a 22% to 65% continuous sucrose gradient. Samples were centrifuged at 30,OOOg for 12 hours. Fractions were collected and analyzed for HIV-1 p24 by antigen capture,' for reverse transcriptase,I8 for HIV-1 gp120 and gp41 by Western blot analyses using human polyclonal anti-HIV-1 sera,' and for buoyant density by refractometry." Amounts of HIV-1 reverse transcriptase and p24 present as viral cores, intact virions, or soluble proteins were estimated by calculating the surface area of each entity between the fractions with buoyant densities of 1.26 to 1.21; 1.20 to 1.14; and less than 1.14 g/mL, respectively.
Mechanism of ozone inactivation
Effects of ozone on HIV-1 envelope protein cell surface receptor interactions were assessed in a competitive binding assay using rhodamine-labeled HIV-1 particles." Briefly, HIV-1 particles were banded on a sucrose gradient, concentrated on a glycerol cushion, and labeled with a rhodamine-linked saturated hydrocarbon, 18 carbons long (R-18) (Molecular Probes, Junction City, OR). Labeled particles were then separated from free R-18 by another centrifugation through 30% glycerol onto a 100% glycerol cushion. Labeled virions were then exposed to HUT 78 cells for 30 minutes at 4°C after the target cells had been pre-exposed to ozone-treated or nontreated, sucrose-banded HIV-1 virions, normalized for p24 and reverse transcriptase content. The degree of rhodaminelabeled HIV-1 binding to the target HUT 78 cells was analyzed on the Epics V flow cytometer. Figure 3A shows the results of an escalating dose regimen on inactivation of cell-free HIV-1. With respect to ozone, the sample was treated sequentially for 1 hour at each of the indicated ozone concentrations. This escalating dose study was designed to define the minimum concentration of ozone at which significant (at least 2 log) virus inactivation was achieved. All curves represent the average of three separate experiments. As can be seen, there was a dose-dependent and time-dependent inactivation of cellfree HIV-1 associated with its passage through this hollow fiber system. The relative contributions of room temperature incubation, mechanical shear, hypoxic atmosphere, and ozone to viral inactivation can be seen in Fig 3A. It is evident that, while ozone is perhaps the major contributing factor to the inactivation of HIV-1 in this system, it is by no means the sole mediator of this event. The results using this escalating dose regimen showed that a threshold dose of 1,200 ppm achieved 2 2 log inactivation of virus. The total concentration multiplied by time at this point was 4,000 ppm hours. Figure 3B shows the results of the time-dependent inactivation of HIV-1 in cell culture medium using 1,200 ppm ozone. As can be seen, 1,200 ppm achieves 2 2 log virus inactivation within 45 minutes (900 ppm hours).
RESULTS
Inactivation due to room temperature, mechanical shear, and nitrogen atmosphere is only approximately 25% within 1 hour. Hence, ozone is the major contributing factor to virus inactivation at both the higher dose and early time points. Figure 4A shows the results of the effect of a sequentially escalating dose of ozone on HIV-1 viability and factor VI11 biologic activity in an HIV-1-spiked human plasma preparation. As can be seen, there is minimal loss of factor VI11 biologic activity associated with ozone treatment at concentrations that eventually inactivate HIV-1. Treatment to a threshold dose of 1,200 ppm results in a 90% inactivation of HIV-1 with only a corresponding 25% loss of factor VI11 biologic activity. Figure 4B shows the results of the time-dependent inactivation of HIV-1 and factor VI11 biologic activity in a plasma preparation using continuous 1,200 ppm ozone. As can be seen, 1,200 ppm ozone achieves 2 2 log inactivation of HIV-1 by 2 hours while the corresponding factor VI11 activity remains high (90%).
Similar results were seen when immunoaffinity-purified factor VI11 preparations were inoculated with HIV-1 and treated continuously with 1,200 ppm ozone (Fig 5) . In this instance, 2 2 log viral inactivation was achieved within 1 hour, whereas factor VI11 activity after 2 hours was approximately 90%. In an effort to determine the degree of inactivation of HIV-1 by ozone, HIV-1-spiked CM (35 mg protein/mL) and HIV-1-spiked plasma (435 mg protein/mL) were each treated with 1,200 ppm ozone for 2 hours. Fifty microliters of each of these treated materials (initially containing 35 ng of HIV-1 p24) were placed in a 28-day HIV-1 culture assay and compared with a serial dilution of untreated HIV-1 virus. In this experiment the transmission of an 11 log dilution of untreated virus could still be detected, whereas the transmission of ozonated, undiluted HIV-1 in CM or human plasma could not be discerned, suggesting that 1,200 ppm of ozone for 2 hours achieved a minimum of an 11 log inactivation (Table 1) .
Studies were performed to evaluate the mechanisms of antiviral action of ozone treatment. There were no appreciable effects of ozone-treated CM on the viability, rates of DNA synthesis, and CD4a levels of HUT 78 target cells exposed in mock infections (Table 2 ). However, treatment of HIV-1-infected CM with 1,200 ppm ozone did result in a marked decrease in recoverable sucrose-banded virions as measured by reverse transcriptase and HIV-1 p24 analyses (Fig 6) . In six separate experiments comparing the surface area under the curve for reverse transcriptase activity and p24 antigen content between media treated and untreated with ozone, the loss of recoverable virions ranged from 75% to 93% with a mean of 85%. Western blot analysis of the fractions in Fig 6 for HIV-1 gp41 and gp120 envelope protein content showed a loss of antigen comparable with that seen with reverse transcriptase and p24 gag protein (data not shown). Hence, there was no preferential loss in residual intact virions of envelope antigen or functional reverse transcriptase activity secondaq to ozone.
As shown in Fig 6, there was no appreciable accumulation of viral cores in the ozone-treated CM. All of the All assays were run six times and results equal mean ? 3 SD. *Channels are grouped from 1 to 267 and are on a log scale.
For missing HIV-1 p24 antigen, but not the reverse transcriptase activity, was recovered in the supernatant after the original high speed pelleting step before sucrose banding (data not shown). This result would indicate that ozone treatment led to complete solubilization of most of the treated HIV-1 particles and that, while key epitopes of solubilized HIV-1 p24 could still be detected in the antigen capture assay, functional reverse transcriptase activity was lost secondary to the oxidation of solubilized enzyme. Further evaluation of ozone-treated and untreated HIV-1 sucrose-banded virions for their ability to compete against rhodamine-labeled HIV-1 for cell surface receptor binding has shown an impaired ability of ozone-treated virions to displace HIV-1 (Table 3 ). This experiment was performed twice with similar results. Although further investigation is necessary, the implication is that ozone-treated virions have 
DISCUSSION
Reducing the infectious risk of human blood products is an area of intense research.Mz Inactivation of infectious agents in blood products under conditions that retain their intrinsic protein biologic activities has undergone extensive study. Thermal inactivation of viruses in blood derivatives has been marginally successful, due in part to the thermolability of these components."-25 Methods ranging from gamma-irradiation:6 porous membrane filtration? and solventfdetergent mixtureszE3' have been investigated. To date, tri(n-buty1)phosphate (TNBP) detergent mixtures have demonstrated a minimum 4 to 5 log 10 reduction in a For personal use only. on November 15, 2017. by guest www.bloodjournal.org From variety of lipid-enveloped viruses, including HIV-1, vesicular stomatitis virus, and Sindbis virus, with a concomitant high recovery rate of protein biologic activity. Analogous work in chimpanzees with TNBP-treated, exogenously viral-spiked blood samples with hepatitis B and non-A, non-B (Hutchinson strain) viruses has shown similar log reductions. However, methods eclipsing a 6 log viral reduction with a similar protein recovery are still being explored. In addition, methods that obviate the necessity for removal of the inactivating agent (ie, Sephadex G-25) and/or that are compatible with cellular systems would ultimately be preferable. Ozone has previously been shown to possess potent antiviral activity, especially when used against lipidenveloped viruses. For this reason we investigated the use of ozone as a potential anti-HIV-1 agent. We used a hollow fiber delivery system that maximizes the surface area available for ozone to interact with the fluid material of interest. The system also allows for the precise regulation of concentrations of ozone to be delivered into the hollow fiber cartridge. Afferent as well as efferent concentrations of ozone can also be monitored to determine if saturating levels of ozone are achieved in the treated material. With regard to laboratory safety concerns, this closed system has proven to be safe and leak-proof, thereby reducing possible exposure of laboratory personnel to ozone and human retroviruses to an absolute minimum.
We first examined the ability of ozone to inactivate cell-free HIV-1 in cell-free CM. These results indicate that ozone has potent anti-HIV-1 activity. Preliminary experiments using an escalating dose regimen indicated that a 1,200 ppm dose of ozone achieved a 2 2 log inactivation of virus. The data show that neither incubation of the virus preparation at room temperature and at atmospheric conditions for the duration of the experiment nor mechanical shear created by pumping the virus through the system inactivate the virus to any great extent. However, there was a significant inactivation of the virus due to exposure of virus-containing CM to the stream of carrier nitrogen. Exposure of the virus to pure nitrogen for 6 hours results in an almost 85% inactivation of virus.
During exposure to nitrogen for 6 hours, conditions are completely anoxic and a maximal pH of 8.1 is achieved, whereas with exposure to room air the oxygen concentration is 21% and the maximal pH is 7.58. It is possible that anoxic conditions or pH changes seen with 6 hours of nitrogen exposure contribute to HIV-1 inactivation. Because some HIV-1 inactivation was observed with N, alone, it was necessary to determine the proportion of virus inactivation attributable to ozone over the course of a 6-hour treatment. Comparison of the time-dependent inactivation of virus seen with 1,200 ppm ozone with that seen with pure nitrogen clearly indicates that ozone plays the predominant role in achieving virus inactivation for periods up to 6 hours. Ozone inactivation of HIV-1 occurs relatively quickly compared with any inactivation observed with N, alone. Inactivation of HIV-1 at 45 minutes is 2 2 log when 1,200 ppm ozone is used and only 25% when nitrogen alone is administered.
Investigation of the degree of inactivation of HIV-1 in CM or human plasma by 1,200 ppm ozone for 2 hours indicates a minimum 11 log reduction in viral infectivity, as determined by a 28-day culture assay. Therefore, the effects of temperature, N,, and mechanical shear, which yield an approximate 0.22 log reduction in HIV-1 infectivity, are certainly eclipsed by the 11 log reduction in infectivity achieved by ozone.
We examined the ability of ozone to render blood products, such as factor VI11 plasma preparations, free of HIV-1 without seriously damaging their biologic activity. The escalating dose study indicated that, at 1,200 ppm, ozone can achieve a 90% inactivation of HIV-1 in human plasma with only a corresponding 25% decrease in factor VIII biologic activity. Measurement of exhaust ozone levels indicated that saturating levels of ozone in the factor VI11 preparations were not achieved in this experiment (data not shown) and, thus, longer exposures of HIV-l-containing factor VI11 preparations at the higher ozone concentrations were used to eliminate the virus entirely. Use of 1,200 ppm ozone for a period of 2 hours achieved saturation and resulted in an 11 log inactivation of HIV-1 in the human plasma preparation. Under the same conditions, factor VIII biologic activity was diminished only 10%. Similarly, 2 2 log HIV-1 inactivation in immunoaffinity-purified factor VI11 preparations occurred within 1 hour of exposure to 1,200 ppm of ozone with an approximately 10% loss of factor VIII.
Comparison of the results of inactivation of HIV-1 by high-dose ozone (1,200 ppm) in cell culture media, monoclate, and factor VI11 plasma preparations indicated that a longer exposure time was necessary to achieve total virus inactivation in the plasma factor VI11 preparation. The reason for the apparent protection of HIV-1 from the For personal use only. on November 15, 2017. by guest www.bloodjournal.org From effects of ozone in this experiment is most likely the increased protein levels in the factor VI11 preparation. Such increased protein levels and other plasma components may act to protect the virus from the effects of ozone.32
The exact mechanism by which ozone mediates the inactivation of HIV-1 remains to be elucidated. Our preliminary data indicate that, at the concentrations tested, ozone results in the solubilization of virions. However, the reduction in infectious virus (about lo1') was far greater than the observed reduction in detectable virions (about 85%). This finding suggested that, in addition to the physical destruction of HIV-1 virions, there was a far greater functional impairment of these virions in the infectivity assay. Our data do not suggest that there was any obvious effect of ozone-treated CM on the viability and CD4a levels of the HUT 78 target cells used in the assay. Nor do our results indicate any preferential quantitative effect on HIV-1 envelope proteins and reverse transcriptase levels in the virions. However, there was some suggestion of a deleterious effect on virus binding to cell surface receptors.
Ozone may react with the unsaturated fatty acids in the lipid envelope of the virus, thereby increasing membrane fluidity and resulting in viral inactivation. Alternatively, ozone may react with other components in the virus preparation (serum proteins, fatty acids, etc) to produce secondary reaction products, such as hydroxyperoxides, that in turn mediate the actual viral inactivation. Far more extensive analyses of all components of the HIV-1 life cycle will be required to fully elucidate ozone's antiretroviral activity.
Ozone has potent anti-HIV-1 activity in cell culture media and factor VI11 preparations. Although the exact mechanism by which ozone mediates its effect remains unclear at this time, it is readily apparent that ozone may be of use in rendering factor VI11 and possibly other blood products, both proteinaceous and cellular, free of HIV-1 and other infectious agents.
